Next Article in Journal
Synthesis of Diarylpyrazoles Containing a Phenylsulphone or Carbonitrile Moiety and their Chalcones as Possible Anti-Inflammatory Agents
Previous Article in Journal
A Single Gradient Stability-Indicating Reversed-Phase LC Method for the Estimation of Impurities in Omeprazole and Domperidone Capsules
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Feed Forward Artificial Neural Network: Tool for Early Detection of Ovarian Cancer

by
Ankita THAKUR
1,2,
Vijay MISHRA
2 and
Sunil K. JAIN
2,*
1
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, 400076, MH, India
2
Department of Pharmaceutics, Adina Institute of Pharmaceutical Sciences, Sagar, 470002, M.P., India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2011, 79(3), 493-506; https://doi.org/10.3797/scipharm.1105-11
Submission received: 11 May 2011 / Accepted: 5 July 2011 / Published: 5 July 2011

Abstract

Pathological changes in an organ or tissue may be reflected in proteomic patterns in serum. The early detection of cancer is crucial for successful treatment. Some cancers affect the concentration of certain molecules in the blood, which allows early diagnosis by analyzing the blood mass spectrum. It is possible that exclusive serum proteomic patterns could be used to differentiate cancer samples from non-cancer ones. Several techniques have been developed for the analysis of mass-spectrum curve, and use them for the detection of prostate, ovarian, breast, bladder, pancreatic, kidney, liver, and colon cancers. In present study, we applied data mining to the diagnosis of ovarian cancer and identified the most informative points of the mass-spectrum curve, then used student t-test and neural networks to determine the differences between the curves of cancer patients and healthy people. Two serum SELDI MS data sets were used in this research to identify serum proteomic patterns that distinguish the serum of ovarian cancer cases from non-cancer controls. Statistical testing and genetic algorithm-based methods are used for feature selection respectively. The results showed that (1) data mining techniques can be successfully applied to ovarian cancer detection with a reasonably high performance; (2) the discriminatory features (proteomic patterns) can be very different from one selection method to another.
Keywords: Ovarian cancer; Neural networks; SELDI; Serum proteomics Ovarian cancer; Neural networks; SELDI; Serum proteomics

Share and Cite

MDPI and ACS Style

THAKUR, A.; MISHRA, V.; JAIN, S.K. Feed Forward Artificial Neural Network: Tool for Early Detection of Ovarian Cancer. Sci. Pharm. 2011, 79, 493-506. https://doi.org/10.3797/scipharm.1105-11

AMA Style

THAKUR A, MISHRA V, JAIN SK. Feed Forward Artificial Neural Network: Tool for Early Detection of Ovarian Cancer. Scientia Pharmaceutica. 2011; 79(3):493-506. https://doi.org/10.3797/scipharm.1105-11

Chicago/Turabian Style

THAKUR, Ankita, Vijay MISHRA, and Sunil K. JAIN. 2011. "Feed Forward Artificial Neural Network: Tool for Early Detection of Ovarian Cancer" Scientia Pharmaceutica 79, no. 3: 493-506. https://doi.org/10.3797/scipharm.1105-11

APA Style

THAKUR, A., MISHRA, V., & JAIN, S. K. (2011). Feed Forward Artificial Neural Network: Tool for Early Detection of Ovarian Cancer. Scientia Pharmaceutica, 79(3), 493-506. https://doi.org/10.3797/scipharm.1105-11

Article Metrics

Back to TopTop